Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Short-term Investments (2019 - 2025)

STRATA Skin Sciences' Short-term Investments history spans 7 years, with the latest figure at $1.3 million for Q1 2025.

  • For Q1 2025, Short-term Investments changed 0.0% year-over-year to $1.3 million; the TTM value through Mar 2025 reached $1.3 million, changed 0.0%, while the annual FY2024 figure was $1.3 million, 2.55% down from the prior year.
  • Short-term Investments for Q1 2025 was $1.3 million at STRATA Skin Sciences, up from $1.3 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $7.5 million in Q1 2021 and bottomed at $1.3 million in Q4 2024.
  • The 5-year median for Short-term Investments is $1.3 million (2023), against an average of $2.3 million.
  • The largest annual shift saw Short-term Investments rose 0.81% in 2021 before it dropped 2.55% in 2024.
  • A 5-year view of Short-term Investments shows it stood at $7.5 million in 2021, then plummeted by 81.75% to $1.4 million in 2022, then fell by 1.98% to $1.3 million in 2023, then decreased by 2.55% to $1.3 million in 2024, then grew by 2.62% to $1.3 million in 2025.
  • Per Business Quant, the three most recent readings for SSKN's Short-term Investments are $1.3 million (Q1 2025), $1.3 million (Q4 2024), and $1.3 million (Q3 2024).